wire

New point of attack for breast cancer with poor prognosis
New point of attack for breast cancer with poor prognosis Scientists from the Friedrich Miescher Institute for Biomedical Research describe how the protein phosphatase SHP2 promotes breast cancer with poor prognosis. As they report Medicine, SHP2 is necessary for the maintenance of the few tumor initiating cells (TICs) in a breast tumor.

Transcriptional barcoding of retinal cells identifies disease target cells
Transcriptional barcoding of retinal cells identifies disease target cells By developing a large scale gene expression map for retinal cell types, FMI Neurobiologists have been able to identify the cells in the retina, where the genes causing retinal diseases specifically act. This narrows down the search for a better understanding of the diseases and opens up new avenues for therapeutic approaches.

From stimulus to emotion: A role for cortex in emotional learning
From stimulus to emotion: A role for cortex in emotional learning A team of neurobiologists around Andreas Lüthi at the Friedrich Miescher Institute of Biomedical Research has shown for the first time that cortex, the largest area of the brain that is typically associated with higher functions such as perception and cognition, is also a prominent site of emotional learning.

FMI director Susan Gasser receives highly esteemed Inserm Prize
FMI director Susan Gasser receives highly esteemed Inserm International Prize Susan Gasser, director of the Friedrich Miescher Institute for Biomedical Research of the Novartis Research Foun